With over 15 years of academic experience at prestigious institutions including Helsinki University, RIKEN Yokohama, and Karolinska Institutet, Alessandro Bonetti has built deep expertise in human molecular genetics, non-coding RNAs, next-generation sequencing (NGS), technology development, and neurological disorders. Transitioning to industry, Alessandro has spent the past four years at AstraZeneca, specializing in RNA therapeutics and non-coding targets. He currently leads multiple internal projects and external collaborations, driving innovation in target identification and validation to shape the future of therapeutic discovery.